LSE:RENX (Renalytix AI plc)
About RENX
Renalytix LSE: RENX NASDAQ: RNLX is the founder and global leader in the new field of bioprognosis for kidney health. Weve engineered a proprietary solution that successfully enables early-stage progression risk assessment when it counts the most. Renalytix. Right here until kidney disease isnt.
Renalytix AI plc (LSE: RENX) Latest News
Investing Articles
Why has the Renalytix AI share price jumped?
Investing Articles
£500 to invest? Here’s how I’d look to make a 1,000% return investing in shares
Investing Articles
The Renalytix share price more than doubled in a year: what I’d do now
Investing Articles
The price of this UK tech share is up over 80% in just the last month. Would I buy?
❮2